Part D Gap Rebates Boost Medicare Rx Spending To 9% Gain In 2010
This article was originally published in The Pink Sheet Daily
Drug spending by the Medicare program increased more than by Medicaid or by private payers in 2010, according to an analysis by CMS; expenditures in Medicaid and by private insurance were level with the previous year and consumer out-of-pocket spending declined. Total drug spending across-the-board rose 1.2% to $259 billion.
You may also be interested in...
Updates on Medicare’s ACO program, drug spending trends and Medicare coverage of IVIG.
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.